The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|12|3|233-239

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.12, Iss.3, 2012-09, pp. : 233-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytokines in the Central Nervous System: Targets for Therapeutic Intervention

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 271-280

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin and Synthetic Melatonergic Agonists: Actions and Metabolism in the Central Nervous System

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 189-216

Bentham Science Publishers

Access to resources Recommend Favorite

Excitatory amino acid transporters as emerging targets for central nervous system therapeutics

By Dunlop J.   Zaleska M.M.   Eliasof S.   Moyer J.A.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 543-570

Informa Healthcare

Access to resources Recommend Favorite

Melatonin receptors: potential targets for central nervous system disorders

By Mahle C.D.   Watson A.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 399-406

Informa Healthcare

Access to resources Recommend Favorite

Mitochondria as Therapeutic Targets of Estrogen Action in the Central Nervous System

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 297-313

Bentham Science Publishers

Access to resources Recommend Favorite